Chicago, IL (PRWEB) November 05, 2012
CIA Medical, a Chicago-based medical supply company claims that antibiotic resistant superbugs and Medicaid’s policy to discontinue payments on Hospital Acquired Infections is fomenting change in hospital procedures, medical devices, and even the soaps and chemicals used in surgery preparation and disinfecting equipment.
According to CIA Medical, Hospital Acquired Infections (HAI), a chronic problem in the health-care industry for decades, has been on the hit list of “preventable costs” in medicine for the last few years. Now that HAI are included in Medicaid’s official no-pay policy, hospitals and medical supply companies are worried. Even with innumerable advances in procedures, techniques, and antibiotics, HAI continue to be a problem, and the term “preventable” seems an unreasonable description when one understands the complexity of the problem.
In the past, HAI could be treated with common antibiotics. However, with the advent of the superbugs, most antibiotics are ineffective and even advanced antibiotics have limited success. Superbug HAI transforms the new Medicaid policy from a serious budget concern to a potential financial crisis.
Superbugs aren’t necessarily new. They are the same killer bugs of the past previously rendered inert by antibiotics that have returned in a more evolved antibiotic-resistant form. Treatment with advanced antibiotics takes longer, costs more, and still may not prove effective.
Even though Medicaid deems HAI preventable, prevention has never been a sure thing. However, regardless of previous difficulties, hospitals and medical suppliers are focusing on prevention like never before with new procedures, devices, and methods.
New methods of surgery preparation, including creating better surgical fields and improving sterilization processes for equipment are being implemented. Also, improved surgical scrubs and soaps that overcome superbugs are being used before and after surgery. Previous antibacterial soaps actually created an environment conducive to superbug evolution.
One area of infection problems has been venous catheters and PICC lines. These catheters are indispensible in multiple medical procedures and have no reasonable alternatives. CIA Medical, a major distributer of catheters, claims that medical device manufacturers are rising to the task. Catheters coated with a chlorhexidine solution chemically bonded to the catheter surface with a controlled release, provides for antimicrobial protection and have shown to be effective against superbugs while the catheter is in place. Additionally, silver-alloy coatings have performed well in clinical trials in preventing urinary tract infections.
Despite the above efforts, CIA Medical states that many medical professionals fear a superbug pandemic. By dismissing superbug HAI as a mere medical oversight and refusing to fund treatment, Medicaid may be creating a much bigger healthcare crisis than the one they are supposedly trying to alleviate. According to the CDC, the spread of superbugs creates an environment where a scrape or cut may once again be potentially fatal.